Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

Clinical trial NCT00138216 · COMPLETED

Trial details

NCT number: NCT00138216
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2005-10-01
Primary completion: 2009-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.